Luis Del Valle
Overview
Explore the profile of Luis Del Valle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
4021
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sitta J, De Carlo F, Kirven I, Tackett J, Penfornis P, Dobbins G, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769460
Oncolytic virotherapy has shown great promise in mediating targeted tumor destruction through tumor-selective replication and induction of anti-tumor immunity; however, obstacles remain for virus candidates to reach the clinic. These...
2.
Prouse T, Larter K, Ghosh S, Kumar N, Mohammad M, Del Valle L, et al.
Thromb Res
. 2024 Dec;
245:109233.
PMID: 39626470
No abstract available.
3.
Thylur Puttalingaiah R, Dean M, Zheng L, Philbrook P, Wyczechowska D, Kayes T, et al.
Cells
. 2024 Oct;
13(20.
PMID: 39451254
Potassium ions (K) are critical electrolytes that regulate multiple functions in immune cells. Recent studies have shown that the elevated concentration of extracellular potassium in the tumor interstitial fluid limits...
4.
Monticone G, Huang Z, Hewins P, Cook T, Mirzalieva O, King B, et al.
EMBO Rep
. 2024 Jul;
25(8):3547-3573.
PMID: 39009832
The COVID-19 pandemic reminded us of the urgent need for new antivirals to control emerging infectious diseases and potential future pandemics. Immunotherapy has revolutionized oncology and could complement the use...
5.
Liu Z, Julius P, Mudenda V, Kang G, Del Valle L, West J, et al.
J Neurovirol
. 2024 Jun;
30(3):303-315.
PMID: 38943022
Although previous studies have suggested that subtype B HIV-1 proviruses in the brain are associated with physiological changes and immune activation accompanied with microgliosis and astrogliosis, and indicated that both...
6.
Dai L, Del Valle L, Miley W, Whitby D, Ochoa A, Flemington E, et al.
Oncogene
. 2024 Jun;
43(30):2372.
PMID: 38890430
No abstract available.
7.
Ghonim M, Ju J, Pyakurel K, Ibba S, Abouzeid M, Rady H, et al.
J Inflamm (Lond)
. 2024 Apr;
21(1):14.
PMID: 38689261
Background: The DNA-dependent protein kinase (DNA-PK) complex comprises a catalytic (PRKDC) and two requisite DNA-binding (Ku70/Ku80) subunits. The role of the complex in repairing double-stranded DNA breaks (DSBs) is established,...
8.
Hossain F, Ucar D, Monticone G, Ran Y, Majumder S, Larter K, et al.
Front Immunol
. 2023 Oct;
14:1244159.
PMID: 37901240
Introduction: Triple-negative breast cancer (TNBC) comprises a heterogeneous group of clinically aggressive tumors with high risk of recurrence and metastasis. Current pharmacological treatment options remain largely limited to chemotherapy. Despite...
9.
Vigolo M, Urech C, Lamy S, Monticone G, Zabaleta J, Hossain F, et al.
Cancers (Basel)
. 2023 Aug;
15(15).
PMID: 37568775
Background: The efficacy of CB-103 was evaluated in preclinical models of both ER+ and TNBC. Furthermore, the therapeutic efficacy of combining CB-103 with fulvestrant in ER+ BC and paclitaxel in...
10.
Barbier M, Del Valle L
Viruses
. 2023 Mar;
15(3).
PMID: 36992464
The human neurotropic JCPyV is the widespread opportunistic causative pathogen of the fatal demyelinating disease progressive multifocal leukoencephalopathy; however, it has also been implicated in the oncogenesis of several types...